Jason Harris

Title: Jason Harris: Innovator in Genomic Analysis

Introduction

Jason Harris is a prominent inventor based in San Ramon, California, known for his significant contributions to the field of genomic analysis. With a total of 13 patents to his name, Harris has developed innovative methods that enhance the understanding of tumor purity and nucleic acid sequencing.

Latest Patents

One of his latest patents focuses on estimating tumor purity from single samples. This invention provides methods for estimating tumor purity from tumor samples without the need for matched-normal controls. A set of genomic regions is identified based on nucleic acid sequence data aligned to a reference genome. Each genomic region includes one or more nucleotide-sequence variants relative to the corresponding genomic region of the reference genome. A B-allele frequency distribution for the biological sample is determined based on the B-allele frequency for each genomic region. This distribution is then processed using a trained machine-learning model to estimate a metric identifying tumor purity in the biological sample. Another notable patent involves methods and systems for genomic analysis. This computer-implemented method processes and analyzes nucleic acid sequencing data by combining untargeted and target-specific sequencing data from nucleic acid samples obtained from a subject. The output generated indicates the presence or absence of one or more polymorphisms in the samples.

Career Highlights

Throughout his career, Jason Harris has worked with leading companies in the biotechnology sector, including Illumina Corporation and Personalis, Inc. His work has significantly advanced the capabilities of genomic analysis, making it more efficient and accurate.

Collaborations

Harris has collaborated with notable professionals in his field, including Mark R Pratt and Bryan Crane. These collaborations have further enriched his research and development efforts.

Conclusion

Jason Harris stands out as an influential inventor in genomic analysis, with a strong portfolio of patents that contribute to advancements in the field. His innovative methods continue to shape the future of genomic research and analysis.